Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Gold Trust (IAU) vs Revvity Inc (RVTY) Price & Performance

iShares Gold TrustTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

iShares Gold Trust vs Revvity Inc — how do they compare? iShares Gold Trust trades at $77.69, while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Revvity Inc pays a 0.25% dividend while iShares Gold Trust pays none, and Revvity Inc is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals.

IAURVTY
Sector
Commodities - Metals/AgricultureTechnology
52-Week High
$101.57$117.75
52-Week Low
$61.62$82.26
Market Cap
$12.33B
Enterprise Value
$14.82B
Dividend Yield
0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Gold Trust

IAU, the iShares Gold Trust ETF, trades at $75.35, down 0.2% with a bearish technical signal from moving averages. The ETF tracks physical gold prices, which have shown volatility amid Middle East tensions and shifting Fed rate expectations. Recent institutional activity includes Eurizon Asset Management acquiring 482,015 shares in Q1 2026 while AlTi Global reduced its position by 1.3%.

Gold's outlook balances strong central bank demand against interest rate pressures. The risk/reward appears favorable with limited downside, though Fed policy remains the primary driver. Physical gold demand from Asian markets provides support, but higher rates could continue to cap near-term gains.

Revvity Inc

RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.

The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Gold Trust

IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.

Read more on IAU

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY